Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > Berkshire Hathaway and LATAM
View:
Post by GoldenInvestor on Dec 09, 2021 12:58pm

Berkshire Hathaway and LATAM

Berkshire has an investment in NuBank.  A latam bank.
Berkshire interrest was piqued in the fintech operation and specifically in LATAM!

- not our space, obviously, BUT, shows how the region is evolving and capturing interest of big investors!
Comment by MrMugsy on Dec 09, 2021 1:19pm
Hahaha ... money, food and drugs ... all very important in the developing world. : )
Comment by longrun86 on Dec 09, 2021 2:50pm
I am a shareholder in both Berkshire and Knight. Berkshire disclosed a $475 million interest in Royalty Pharma in November. It's a slightly different business model but generates attracted ROE on a global basis. Latam is gaining interest and I am trying to find a good source of fund flow that is more than anecdotal. Please let me know if you are aware of a reliable source. Best of luck, LR
Comment by MrMugsy on Dec 09, 2021 3:56pm
Longrun ... maybe BNS as a LATAM play ! Pretty sure there's a reliable source of revenue coming from them. : )
Comment by Chianchin on Dec 09, 2021 6:15pm
Scotia bank has taken huge losses and out in many LATAM contries and now they are focusing only in Mexico and Colombia and some island. Royal got out period. Again tMr. Mugsy desperatly tries to confuse andconting losses. No presnts for his grand kids soon
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities